Oppenheimer & CO Inc Sol Gel Technologies Ltd. Transaction History

Oppenheimer & CO Inc

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2020 Nov 13, 2020	SELL	$7.15 - $8.73 $82,217 - $100,386	-11,499 Closed	0 $0
Q2 2020 Aug 11, 2020	BUY	$6.15 - $9.4 $70,718 - $108,090	11,499 New	11,499 $103,000

5.35M

1.5K

Ticker SLGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 23,129,500
Market Cap $10.2M
Description
Sol-Gel Technologies Ltd., a clinical stage specialty pharmaceutical company, focuses on developing and commercializing topical dermatological drug products based on its proprietary microencapsulation delivery system in Israel. The company's lead product candidates include Twyneo, a novel, once-daily, non-antibiotic topical cream which has compl...

Get notified when there are updates to the investment portfolio of Oppenheimer & CO Inc, based on Form 13F filings with the SEC.

Stay updated on Oppenheimer & CO Inc with notifications on news.